Les employés de Covance qui facilitent les essais cliniques reconnaissent qu'ils aident à faire avancer la médecine et améliorer les soins de santé, mais, parfois, l'impact est beaucoup plus concret.
« Un de nos clients testait une nouvelle formule pour le vaccin contre la rougeole, les oreillons, la rubéole et la varicelle (RORV) et devait s'assurer que le produit final ne présentait pas de danger chez la population pédiatrique », explique Joshua. L'étude en phase IV avançait bien mais avait besoin d'un attaché de recherche clinique (ARC). Joshua a été ravi de se charger de l'étude et de renforcer son expérience.
A few days later, Joshua was on a plane and visiting a pediatric clinic to monitor the site, the study and its resulting data. He worked closely with the clinic to anticipate and resolve issues and after several months of traveling between the clinic and his home base, the study wrapped up.
"It is nice feeling to close a study," said Joshua. "There is the satisfaction of being on a study start to finish. And, it was a well-run study so the new vaccine received FDA approval."
But the biggest satisfaction was yet to be realized. About a year later, Joshua's wife took one of their children for a routine physical, which included a vaccination.
"I was glancing at the info sheet that the pediatrician sent home and I realized my daughter received the MMRV vaccine that I supported. When I told my daughter, she couldn't believe that she got 'the shot that Daddy made,' as she called it," he laughed.
"Sometimes in this role we may feel disconnected from the whole process," admitted Joshua, "but this coincidence gave me a direct connection to the important work that we do as CRAs. It just shows that what we do at Covance really makes a difference in people's lives."